Elevation in serum uric acid levels predicts favourable response to erlotinib treatment in patients with metastatic non-small-cell lung cancer.
J Clin Pharm Ther
; 45(2): 303-308, 2020 Apr.
Article
in En
| MEDLINE
| ID: mdl-31778239
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Uric Acid
/
Carcinoma, Non-Small-Cell Lung
/
Protein Kinase Inhibitors
/
Erlotinib Hydrochloride
/
Lung Neoplasms
Type of study:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Clin Pharm Ther
Journal subject:
FARMACIA
/
TERAPEUTICA
Year:
2020
Document type:
Article
Affiliation country: